Roberta Ballard
Publications
- Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant.
- Composition and origin of lung fluid proteome in premature infants and relationship to respiratory outcome.
- Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE).
- Ancestry and genetic associations with bronchopulmonary dysplasia in preterm infants.
- Surfactant status and respiratory outcome in premature infants receiving late surfactant treatment.
- Reply.
- Maternal Black Race and Persistent Wheezing Illness in Former Extremely Low Gestational Age Newborns: Secondary Analysis of a Randomized Trial.
- Race Effects of Inhaled Nitric Oxide in Preterm Infants: An Individual Participant Data Meta-Analysis.
- Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development.
- Reply.
- The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age.
- Characteristics of Extremely Low Gestational Age Newborns Undergoing Tracheotomy: A Secondary Analysis of the Trial of Late Surfactant Randomized Clinical Trial.
- Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns.
- High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.
- Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials.
- Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program.
- Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide.
- Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States.
- Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach.
- Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.
- Inhaled nitric oxide increases urinary nitric oxide metabolites and cyclic guanosine monophosphate in premature infants: relationship to pulmonary outcome.
- Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study.
- Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
- Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials.
- Pilot trial of late booster doses of surfactant for ventilated premature infants.
- Re: 'The use of iNO in the newborn period: results from the European iNO registry'.
- Inhaled nitric oxide in preterm infants: a systematic review and individual patient data meta-analysis.
- Two-year neurodevelopmental outcomes of ventilated preterm infants treated with inhaled nitric oxide.
- Accounting for multiple births in neonatal and perinatal trials: systematic review and case study.
- Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
- Inhaled nitric oxide in premature infants: effect on tracheal aspirate and plasma nitric oxide metabolites.
- Expression of nitric oxide synthases and endogenous NO metabolism in bronchopulmonary dysplasia.
- One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial.
- Inhaled nitric oxide for preterm infants.
- Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants.
- Therapeutic hypothermia changes the prognostic value of clinical evaluation of neonatal encephalopathy.
- Inhaled nitric oxide in preterm infants--correction.
- The effect of inhaled nitric oxide on pulmonary function in preterm infants.
- Surfactant function and composition in premature infants treated with inhaled nitric oxide.
- Determinants of outcomes after head cooling for neonatal encephalopathy.
- Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide.
- Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
- Urinary metabolites of oxidative stress and nitric oxide in preterm and term infants.
- Neonatal - perinatal medicine fellowship training in long-term outcomes of neonatal intensive care unit graduates.
- Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial.
- Dysfunction of pulmonary surfactant in chronically ventilated premature infants.
- Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease.
- Surfactant protein profile of pulmonary surfactant in premature infants.
- Plasma 3-nitrotyrosine and outcome in neonates with severe bronchopulmonary dysplasia after inhaled nitric oxide.
- Pulmonary surfactant for neonatal respiratory disorders.
- Interaction of endogenous endothelin-1 and inhaled nitric oxide in term and preterm infants.
- Fear of litigation may increase resuscitation of infants born near the limits of viability.
- Multiple courses of antenatal corticosteroids are associated with early severe lung disease in preterm neonates.
- Association of plasma cortisol and chronic lung disease in preterm infants.
- Clinical use of antenatal corticosteroids: benefits and risks.
- Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group.
- Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia.
- Antenatal hormone therapy for fetal lung maturation.
- Plasma thyroid hormones in premature infants: effect of gestational age and antenatal thyrotropin-releasing hormone treatment. TRH Collaborative Trial Participants.
- Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia.
- Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group.
- Antenatal hormone therapy for improving the outcome of the preterm infant.
- Partial deficiency of surfactant protein B in an infant with chronic lung disease.
- Thyrotropin-releasing hormone for prevention of neonatal respiratory disease.
- Outcome of very low birth weight infants: multiple gestation versus singletons.
- Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone.
- Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. TRH Study Group.
- Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
- Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
- Effect of medical and social risk factors on outcome of prematurity and very low birth weight.
- Theophylline treatment in the extubation of infants weighing less than 1,250 grams: a controlled trial.
- Developmental follow-up of infants with persistent pulmonary hypertension of the newborn.
- Risk factor analysis of intraventricular hemorrhage in low-birth-weight infants.
- Prenatal administration of betamethasone for prevention of patient ductus arteriosus.
- Fetal sex and prenatal betamethasone therapy.
- Glucocorticoids in prevention of respiratory distress syndrome.
- Control of oxygenation during the transport of sick neonates.
- Preliminary observations on the behavior of children present at the birth of a sibling.
- Nosocomial respiratory syncytial virus infections in an intensive care nursery: rapid diagnosis by direct immunofluorescence.
- Acquired cytomegalovirus infection in preterm infants.
- What pediatricians say to mothers of sick newborns: an indirect evaluation of the counseling process.
- Corticosteroids and respiratory distress syndrome: status 1979.
- Prenatal administration of betamethasone for prevention of respiratory distress syndrome.
- Use of prenatal glucocorticoid therapy to prevent respiratory distress syndrome. A supporting view.
- Hydrocephalus secondary to intracranial hemorrhage in premature infants.
- Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome.
- Cytoplasmic receptor for glucocorticoids in lung of the human fetus and neonate.
- Idiopathic respiratory distress syndrome. Treatment with continuous negative-pressure ventilation.